Accessibility Menu
Manhattan Scientifics logo

Manhattan Scientifics(OTC) MHTX

Market Cap$600.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1997)-100%
5 Year-100%
1 Year+0%
1 Month+0%
$0.00
+0.00%
+0.00Today
Manhattan Scientifics last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-28
Manhattan Scientifics stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-07-13
1 month+0%USD 0.002026-06-26
3 month+0%USD 0.002026-04-17
Year to date+0%USD 0.002025-12-30
1 year+0%USD 0.002025-07-25
3 year-99.98%USD 0.012023-07-28
5 year-100%USD 0.032021-07-29
Since inception-99.99%USD 0.011997-12-08

Manhattan Scientifics Financials at a Glance

Market Cap

$600.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$2.00K

Net Income (TTM)

-$1.06M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

1.21 (Average)

Price

$0.00

Volume

10,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Aug 22, 2025

MHTX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Manhattan Scientifics

Manhattan Scientifics, Inc. is an innovation hub focused on advancing technologies that enhance human life, particularly in nanotechnology and nanomedicine. Established in 1992 and headquartered in New York City, the company aims to bring groundbreaking solutions to market.

Products and Services
  • Development of nanotechnology applications for medical devices
  • Research initiatives in nanomedicine to improve healthcare outcomes
  • Collaboration with industry partners to commercialize innovative technologies
Growth Outlook
  • Significant investment in research and development, totaling $2,000 in Q2 2024
  • Potential for market expansion in the growing nanotechnology sector
  • Focus on strategic partnerships to enhance product offerings and reach
Financial Highlights
  • Q2 2024 net income of -$158,000, reflecting ongoing investment in R&D
  • Trailing twelve months (TTM) revenue of $0, indicating early-stage development
  • Cash and cash equivalents of $38,000 as of June 30, 2024
Manhattan Scientifics, Inc. operates in a niche market with a focus on innovative technologies that have the potential to transform healthcare. The company's commitment to research and development is evident in its financials, with consistent investments aimed at advancing its product offerings. Despite reporting no revenue in recent quarters, the strategic focus on nanotechnology positions the company for future growth as the market for these technologies expands. The financial data indicates a challenging environment, but the potential for partnerships and advancements in nanomedicine could provide pathways for success. Investors may find interest in the company's long-term vision and its role in a rapidly evolving industry.
AI Generated • Jul 24, 2026

Industry

Biotechnology

CEO

Emmanuel Tsoupanarias

Headquarters

New York City, NY 10001, US

MHTX Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

66.63%

Return on Capital

N/A

Return on Assets

-368.67%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$600.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

559.28M

Volume

10.00K

Avg. Volume

43.15K

Financials (TTM)

Gross Profit

$1.00K

Operating Income

-$683.00K

EBITDA

-$865.75K

Operating Cash Flow

-$110.00K

Capital Expenditure

$0.00

Free Cash Flow

-$110.00K

Cash & ST Invst.

$38.00K

Total Debt

$60.00K

Manhattan Scientifics Performance Analysis

Manhattan Scientifics annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 50,000N/A
20222022-12-31USD 50,0000.0%
20232023-12-31USD 0N/A
Manhattan Scientifics sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32023-09-30N/A
Q42023-12-31N/A
Q12024-03-31-100.0%
Q22024-06-30N/A
Manhattan Scientifics annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -0.01N/A
20222022-12-31USD -0.00-24.6%
20232023-12-31USD -0.00-57.1%
Manhattan Scientifics sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32023-09-30-25.0%
Q42023-12-31N/A
Q12024-03-31-40.0%
Q22024-06-3057.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2024YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$600.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$600.00

N/A

Employees

1

N/A

Net Income

-$158.00K

+31.0%

EBITDA

-$158.00K

+14.6%

Quarterly Fundamentals

Name
Q2 2024YOY CHG

Total Cash

$38.00K

-26.9%

Total Debt

$60.00K

-14.3%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$60.00K

-14.3%

Return on Assets

-3.69%

N/A

Return on Invested Capital

39.01%

N/A

Free Cash Flow

-$17.00K

+73.4%

Operating Cash Flow

-$17.00K

+73.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IPAHInterpharm Holdings, Inc.
$0.00+0.00%
OWCPOWC Pharmaceutical Research Corp.
$0.00+0.00%
LADXLadRx Corporation
$0.01-89.72%
BIOIFBiome Grow Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$162.66+0.29%
SPCXSpace Exploration Technologies
$125.33+0.09%
NVDANvidia
$211.94+0.03%
INTCIntel
$100.86+0.11%

Questions About MHTX

What is the current price of Manhattan Scientifics?

Manhattan Scientifics is trading at $0.00 per share.

What is the 52-week range for Manhattan Scientifics?

Over the past 52 weeks, Manhattan Scientifics has traded between $0.00 and $0.00.

How much debt does Manhattan Scientifics have?

As of the most recent reporting period, Manhattan Scientifics reported total debt of $60.00K.

How much cash does Manhattan Scientifics have on hand?

Manhattan Scientifics reported $67.00K in cash and cash equivalents in its most recent financial results.

What is Manhattan Scientifics’s dividend yield?

Manhattan Scientifics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.